DICI Interactive Summary
Drug-Induced Cardiac Injury (DICI) - Safety Officer Interactive Tool
This structured tool supports patient safety officers in identifying, evaluating, and managing drug-induced cardiac injury.
| Drug Class | Examples | Cardiac Effects |
|---|---|---|
| Chemotherapy Agents | Anthracyclines, Trastuzumab, TKIs | Cardiomyopathy, Heart Failure |
| Anti-Inflammatory Drugs | NSAIDs, Corticosteroids | Hypertension, Fluid Retention, Stroke Risk |
| Psychotropic Drugs | TCAs, Atypical Antipsychotics | Arrhythmias, Metabolic Syndrome |
| Antiarrhythmic Drugs | Amiodarone | Bradycardia, QT Prolongation |
| Antihypertensive Drugs | Beta-blockers, ACE inhibitors | Withdrawal Effects, Hypotension |
| Illicit Drugs | Cocaine, Amphetamines | MI, Arrhythmias, Vasoconstriction |
| Miscellaneous | Hydroxychloroquine, Antihistamines | QT Prolongation, Cardiomyopathy |
| Mechanism | Examples | Description |
|---|---|---|
| Direct Myocardial Toxicity | Anthracyclines | Free radical damage causing cardiomyopathy |
| Ion Channel Interference | Antiarrhythmics, Antihistamines | QT Prolongation, Risk of Torsades |
| Coronary Artery Constriction | Cocaine | Vasospasm leading to ischemia |
| Negative Inotropic Effects | Beta-blockers | Reduced contractility, worsening heart failure |
| Metabolic Disturbances | Antipsychotics, Antidepressants | Weight gain, metabolic syndrome increasing CVD risk |
| Electrolyte Imbalances | Diuretics | Hypokalemia-induced arrhythmias |
| Onset Category | Example | Risk Window | Time to Onset |
|---|---|---|---|
| Immediate | Cocaine | Upon Use | Minutes to Hours |
| Early | NSAIDs | Initiation or High Dose | Days |
| Subacute | Trastuzumab | Early Treatment Phase | Weeks to Months |
| Late | Anthracyclines | Cumulative Dose Dependent | Months to Years |
| Variable | ACE inhibitors | With Dose Changes or Renal Impairment | Anytime |
| Idiosyncratic | QT Prolongation Drugs | Unpredictable | Single Dose or Chronic |
| Alternative Explanation | Potential Causes |
|---|---|
| Pre-existing CVD | Undiagnosed CAD, coincidental MI |
| Structural Heart Disease | Hypertrophic Cardiomyopathy |
| Infections | Viral Myocarditis |
| Electrolyte Imbalances | Diuretic-induced Hypokalemia |
| Stress Cardiomyopathy | Takotsubo Syndrome |
| Endocrine Causes | Hyperthyroidism-induced Palpitations |
| Illicit Substance Use | Cocaine or Methamphetamine |
- Definition: Structural, functional, or electrophysiological cardiac abnormality temporally linked to drug exposure, excluding other likely causes.
- Diagnostic Requirements:
- New cardiac symptoms or abnormal exam
- Objective evidence (biomarkers, ECG, Echo)
- Temporal link to drug exposure
- Reasonable exclusion of other causes
- Reversibility or rechallenge (if applicable)
- Example: Reduced LVEF post-Doxorubicin with no other cause = Likely DICI
- High-risk drugs include anthracyclines, NSAIDs, psychotropics, and illicit substances
- Common injury mechanisms: oxidative stress, QT prolongation, metabolic effects
- Time to onset ranges from minutes (cocaine) to years (anthracyclines)
- Exclude alternative diagnoses before confirming DICI
- Management: discontinue offending drug, monitor cardiac status, educate patients
